FIGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price action is still weak/indecisive (MACD below zero, RSI ~37) and the stock is trading below the key pivot (11.104), which limits upside follow-through.", "Options positioning is bullish (very low put/call ratios), but absolute option volume is small\u2014so sentiment looks optimistic, not strongly conviction-backed.", "Insiders are selling aggressively (selling amount up ~101.7% over the last month), which is a meaningful near-term negative signal.", "Next major catalyst is earnings (QDEC 2025) on 2026-03-02 after hours; with an impatient profile, buying ahead of earnings without a clear technical reversal is not attractive.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Trend/momentum: MACD histogram -0.12 (below 0) but negatively contracting \u2192 downside momentum is easing, yet trend is not confirmed bullish.", "RSI(6) ~37.3 \u2192 weak/near-oversold behavior; can support a bounce, but not a buy signal by itself.", "Moving averages: converging \u2192 consolidation/transition phase rather than a clear uptrend.", "Key levels: Pivot 11.104 (overhead), resistance R1 11.627 / R2 11.951; support S1 10.581 / S2 10.257.", "Tactical read: a cleaner buy setup would be a reclaim/hold above 11.10 (pivot) or a washout toward 10.58\u201310.26 with stabilization; at 10.91 it\u2019s stuck in the middle.", "Pattern-based forward stats: ~60% chance of -0.45% next day, +1.62% next week, +5.58% next month (mildly constructive beyond the very near term)."]
["Earnings catalyst upcoming: QDEC 2025 earnings on 2026-03-02 (after hours); can re-rate the stock if margins/guide surprise positively.", "Analyst price targets have been trending upward since Q3 strength (multiple raises from Nov 2025 through Jan 2026).", "Gross margin improved in the latest reported quarter (2025/Q3), supporting the quality of revenue growth if sustained."]
["Insider selling is elevated (selling amount up ~101.69% over the last month).", "Profitability deterioration in latest quarter: net income and EPS fell sharply YoY despite revenue growth (suggesting cost/one-time pressures or operating leverage issues).", "Technical posture is not yet bullish (MACD below zero; price below pivot resistance at 11.104).", "No supportive news flow in the last week; absent catalysts, the stock may chop until earnings."]
["Latest quarter: 2025/Q3.", "Revenue: $151.661M, +8.17% YoY (steady top-line growth).", "Gross margin: 69.94%, +4.29% YoY (positive mix/pricing/efficiency signal).", "Net income: $8.746M, -614.47% YoY; EPS: $0.05, -600% YoY (profitability trend is the key concern despite better gross margin)."]
["Recent rating trend: mixed\u2014multiple Buy-equivalent voices raising targets (BTIG, Roth), several Neutral/Market Perform maintaining cautious stance (Barclays, Morgan Stanley, Telsey), and Goldman staying Sell despite raising its target.", "Price target changes (recent): BTIG up to $15 (Buy); Roth up to $12 (Buy); Barclays up to $11 (Equal Weight); Morgan Stanley up to $7.50 (Equal Weight); Goldman up to $7.50 (Sell).", "Wall Street pros: improving brand/business momentum narrative and margin opportunities; international/teams/community initiatives cited as growth drivers.", "Wall Street cons: profitability/margin recovery execution risk and potential headwinds (e.g., tariffs mentioned by Telsey); Goldman remains structurally bearish (Sell) even after raising target."]
